TMN-018001
Namodenoson
(2S,3S,4R,5R)-5-(2-Chloro-6-((3-iodobenzyl)amino)-9H-purin-9-yl)-3,4-dihydroxy-N-methyltetrahydrofuran-2-carboxamide;2-Cl-IB-MECA;(2S,3S,4R,5R)-5-[2-chloro-6-[(3-iodophenyl)methylamino]purin-9-yl]-3,4-dihydroxy-N-methyloxolane-2-carboxamide;2-Chloro-N6-(3-iodobenzyl)adenosine-5'-N-methyluronamide;b-D-Ribofuranuronamide,1-[2-chloro-6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-1-deoxy-N-me...;b-D-Ribofuranuronamide,1-[2-chloro-6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-1-deoxy-N-methyl-;CF-102;Chloro-IB-MECA;2-chloro-IB-MECA;CF102;CI-IB-MECA;Cl-IB-MECA;2-Chloro-N6-(3-iodobenzyl)-adenosine-5′-N-methyluronamide;Netazepide;2-CL-IB-MECA;2-Cl-IB-MECA (CF-102);Cl-IB-MECA, 2-Chloro-N6-(3-iodobenzyl)-adenosine-5μ-N-methyluronamide;1-[2-Chloro-6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-1-deoxy-N-methyl-β-D-ribofuranuronamide;1-[2-chloro-6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-1-deoxy-N-methyl-b-D-ribofuranuronamide;b-D-RibofuranuronaMide,1-[2-chloro-6-[[(3-iodophenyl)Methyl]aMino]-9H-purin-9-yl]-1-deoxy-N-Methyl-
Open
163042-96-4
C18H18CLIN6O4
544.73